Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02342379
Title TH-302 in Combination With Bevacizumab for Glioblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors The University of Texas Health Science Center at San Antonio
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field